GLP-1 drugs are now a fixture of American health culture: 1 in 8 U.S. adults is taking a medication like Ozempic or Wegovy, ...

Breaking into established markets requires strategic vision, passion, and relentless execution. This episode explores how to ...

Food system advisory firm Bramble Intelligence examines the intersection of appetite-suppressing drugs, AI, and at-home ...

How I used the chatbots Gemini and Claude as an AI personal trainer to take the guesswork out of diet and exercise.

The field of food systems research is increasingly focused on the intersecting challenges of climate change, market ...

Although the book told an intimate story, it captured the contradictions and distortions in America’s food landscape, where ...

The recently released National Family Health Survey (NFHS)-6 report presents a mixed progress card for India, offering reasons to cheer while also sending clear signals to pause and reflect. On the ...

Nigeria’s sugary drinks tax was meant to stop rising diabetes rates, but soaring inflation has eroded its impact. Experts say the levy is too small to change behaviour and urge higher rates and ...

GLP-1 weight-loss drugs are reshaping confectionery demand - but not killing it. As global sales continue to grow, brands ...

Inflation, health concerns and AI-powered product reviews are reshaping snacking. NIQ’s Chris Costagli explains how snack brands can win today’s shoppers.

A record 11% of Americans now use GLP-1 drugs for weight loss, according to a new Gallup survey. Here’s what the rise of ...

Adults with high blood pressure got another reason to pay attention to what they eat when the DASH diet earned a consecutive top ranking as the best heart-healthy eating plan. Backed by the National ...